Drug Review, Safety and Cost Effectiveness

Drug review decisions must incorporate a broad range of relevant experts, including specialist physicians who treat patients living with disease the drug is intended to treat, as well as taking into consideration the uniqueness of disease experience.

Decisions about drug safety are an integral and ongoing part of the review process, and must incorporate all relevant stakeholders, including specialist physicians, epidemiologists and patients.

Decisions about the cost effectiveness of medications must include an examination of the full economic impact across the whole health system as well as those areas of government significantly impacted by indirect health care costs.